Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fortrea Holdings Inc. | 38,817 | reported | 10 Jun 2025 | tx 7+66,089−13,636 |
| Ultragenyx Pharmaceutical Inc. | 14,058 | reported | 14 May 2026 | tx 12+88,741 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,751 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,058 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Fortrea Holdings Inc. | 38,817 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,740 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 10,787 | 0.00 USD | deriv |
| 14 May 2025 | EXERCISE | Fortrea Holdings Inc. | 7,282 | 0.00 USD | |
| 14 May 2025 | EXERCISE | Fortrea Holdings Inc. | 7,282 | 0.00 USD | deriv |
| 18 Jul 2024 | EXERCISE | Fortrea Holdings Inc. | 6,354 | 0.00 USD | |
| 18 Jul 2024 | EXERCISE | Fortrea Holdings Inc. | 6,354 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,345 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,900 | 0.00 USD | deriv |
| 14 May 2024 | GRANT_AWARD | Fortrea Holdings Inc. | 7,282 | 0.00 USD | deriv |
| 18 Jul 2023 | GRANT_AWARD | Fortrea Holdings Inc. | 6,354 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,860 | 0.00 USD | |
| 07 Jun 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,110 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,300 | 0.00 USD | |
| 24 Jun 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 6,245 | 0.00 USD | deriv |
| 19 Apr 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,120 | 0.00 USD | |
| 19 Apr 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,525 | 0.00 USD | deriv |